Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea.

Diabetes Metab J · 2019 · PMC6712234 · PMID 31237133

Europe PMC DOI

hedged sentence

0.2230

closest p · 4.5× alpha

0.2230

boldest claim

The sentences

did not reach statistical significanceP =0.223not close (p > 0.1)

21.8±13.5 U in SU nonusers), but this difference did not reach statistical significance ( P =0.223) ( Supplementary Table 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.